A B S T R A C T Sodium salicylate was administered to anesthetized dogs in doses sufficient to produce concentrations in plasma comparable to those common in human salicylate toxicity. Salicylate administration increased the rates of excretion of water, sodium, and chloride in the urine. Salicylate administration also increased the rate of excretion of potassium so that its clearance often exceeded that of creatinine. This enhancement of potassium excretion was dissociated from the alkalosis that accompanies salicyate toxicity. Administration of 5% C02 in inspired gas did not attenuate the excretion of potassium; injection of salicylate into one renal artery caused a unilateral kaliuresis. Phosphate excretion increased progressively after administration of salicylate. On several occasions the clearance of phosphate equalled that of creatinine. Salicylate reduced renal tubular glucose reabsorption. When salicylate was injected into a renal artery, a glycosuria occurred ipsilaterally at filtered loads of glucose far below the reabsorptive capacity of the dog kidney. Salicylate administration also was associated with early elevation of glucose, phosphate, and potassium concentration in plasma. Salicylate administration reduced the content of adenosine triphosphate in the renal medulla. Salicylate was concentrated within the medulla between 1.5 and 3 times that of the cortex, a gradient equal to that for chloride. Received for publication 20 October 1970 and in revised form 16 July 1973. in adults is respiratory alkalosis. In children, and late in the course of salicylate poisoning in adults, the dominant change is metabolic acidosis. The acidosis probably is due to accumulation of lactic and other organic acids (1) . Reports of other alterations in composition of extracellular fluid are conflicting. The concentration of potassium in plasma has been reported as increased (2) , decreased (3), or unchanged (4, 5) . Hyperglycemia (6) as well as hypoglycemia (7) is described. Values of plasma phosphate concentration have been reported as unchanged (4) , and the occasional observation of elevated phosphate was attributed to prerenal azotemia (8) . Dehydration is a prominent feature of salicylate toxicity and has been attributed to vomiting, fever, sweating, and lack of adequate fluid intake, but not to diuresis.
INTRODUCTION
References to the effects of salicylate on renal excretion of salt and water are few and the results are variable. Polyuria has been noted (8) , although oliguria has also been described (6, 9) . Sodium excretion has been reported unchanged (4) , decreased (10, 11) , and increased (12) . Observations on phosphate excretion also are controversial (4, 11, 12) . Such discrepancies may be explained by species differences and by differences in dose, duration of observation and other experimental variables. It is generally assumed that potassium loss is secondary to respiratory alkalosis (8, 9, 13) . Only one report, in abstract form, has challenged this viewpoint (14) .
The present report describes the acute effects .of toxic doses of salicylate administered systemically and by renal artery infusion on renal function in the anesthetized dog. Salicylate caused a natriuresis associated with chloruresis and diuresis in confirmation of the findings of Ramsay and Elliott (12) . Unilateral administration of the compound produced a unilateral kaliuresis during respiratory acidosis caused by inspiration of 5% CO2. Glycosuria and phosphaturia were noted without alteration in the filtered loads of these substances.
The Journal of Clinical Investigation Volume 52 December 1973-3143-3153 In addition, we found in experimental animals that salicylate accumulated in the renal medulla to an extent approximating the gradient for chloride. Salicylate also reduced the concentration of ATP in the renal cortex.
METHODS
Two types of experiments were performed in fasting dogs, weighing 15-20 kg, lightly anesthetized with pentobarbital. In six experiments salicylate was injected intravenously; in seven experiments salicylate was inj ected directly into one renal artery.
Experiments with i.v. injection. The dogs were given approximately 1000 ml isotonic saline solution i.v. in 1 h followed by a continuous infusion of isotonic saline solution containing 5 g of creatinine per liter, at a rate of 5 ml/min. Urine was collected from each kidney by direct ureteral catheterization. Samples of blood were taken from a femoral artery. Urine samples were collected only when rates of urine flow were approximately equal in both kidneys. Two control collections were obtained from each kidney at 10-min intervals. Typically, the interval between onset of fluid administration and initiation of clearance collections was 2 h. Control periods were followed by administration of sodium salicylate (Sigma, reagent grade) dissolved in 50 ml of water, injected intravenously over 5 min in a dose of 3 mmol/kg body weight. Subsequent collections were made at 10-min intervals for 60-80 min.
To ascertain that the results were not due to volume expansion, a control series of four experiments were carried out under identical conditions, except that sodium chloride (Baker, reagent grade) in a dose of 3 mmol/kg body weight was injected intravenously instead of salicylate.
Experiments with intraarterial infusion. In seven experiments the left kidney was approached retroperitoneally by an incision in the flank with blunt dissection of the underlying muscles. A small, curved needle was inserted into the left renal artery which was being perfused at 1.38 ml/min with an isotonic saline solution. The experimental preparation was otherwise similar to the one used for i.v. injection. After two control clearance periods, a 0.36 M solution of sodium salicylate was infused directly into the renal artery at the rate of 1.38 ml/min (0.5 mmol/min). Experimental observations were continued for 60-80 min of salicylate infusion. We also performed four additional control studies in which the experimental conditions were identical with the above except that a 0.36 M solution (0.5 mmol/min) of sodium chloride was injected instead of salicylate.
Upon completion of an experiment, the left kidney was exteriorized through the flank incision and sliced with a three-bladed knife. The slices were dropped into liquid nitrogen, which freezes the tissue within 8 s of interruption of its blood supply (15, 16) . Frozen samples of cortex and inner medulla were separated and their content of adenine nucleotides measured by a modification (16) of the Cohen and Carter method (17) . In six experiments, the concentration of salicylate and chloride was measured in cortex, outer medulla, and inner medulla after chipping off portions of tissue of these zones from frozen slices. The tissues were ground in the cold, weighed, and let stand overnight in 5 times their weight of water at 4VC (18) . These specimens were centrifuged and decanted, and the supernatant was analyzed for salicylate and chloride content.
Creatinine was measured by the method of Jaffe as modified by Smith (19) , PAH by the method of Smith et al. (20) , and inorganic phosphate by the method of Chen et al. (21) . Salicylate was measured by the method of Brodie et al. (22) and glucose by the glucosoxidase method (23) . Sodium and potassium were determined by flame photometry and chloride by the Cotlove chloridometer.
RESULTS

Systemic infusion
The results of six experiments in which salicylate was injected intravenously are presented in Table I Toward the end of these observations the ratio of potassium clearance to creatinine clearance varied from 1.05 to 2.0 (Fig. 2) . This is evidence for tubular secretion of potassium. In two experiments the dogs inhaled 5% C02 in air. This maneuver, which produces a moderate respiratory acidosis, did not alter the kaliuresis.
Potassium clearance in these two experiments was 8.6 and 6.7 ml/min before administration of salicylate and increased to 29.4 and 44.6 ml/min, respectively, during infusion of salicylate despite inhahtion of C02.
Intraarterial infusion
Data of seven experiments in which salicylate was injected unilaterally are presented in Table III . Samples of two 10-min clearance periods were collected as controls. Direct injection into the renal artery permitted the use of smaller doses of salicylate than those employed by intravenous route.
In every instance, a diuresis was produced exclusively on the injected side. Mean urinary volume on the left
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A. Quintanilla and R. H. Kessler side increased from 1.90 ml/min during the control periods to 5.40 ml/min during the last experimental period. Water excretion on the contralateral side was unchanged or decreased. On the experimental side, creatinine clearance declined slightly in some experiments and, in one case, increased modestly during the last experimental period. Phosphate clearances increased in both kidneys but predominantly in the infused side. The mean Cpo4 in the left kidney during control periods was 9.8 ml/min and 23.1 in the last period; in the right side the increase was from 8.7 to 14.8 ml/nmin. Sodium clearance changed only from 2.35 to 2.47 ml/min on the right side, while on the experimental side it increased from 2.64 to 5.89 ml/min. Potassium clearance increased on the experimental side in every experiment and bilaterally in three of seven studies. Mean potassium clearance on the right side increased from 9.3 to 18.6 ml/min and from 9.8 to 27.4 ml/min in the left side. The rates of excretion of sodium and potassium in one such experiment are shown graphically in Fig. 3 .
The results of four control experiments with sodium chloride are presented in Table IV periods sodium chloride was infused into the renal artery at a molar rate equal to or higher than salicylate. This infusion did not cause any significant enhancement in the excretion of sodium, potassium, or phosphate in the injected side in contrast with the effects produced by infusion of salicylate. The effects of salicylate on plasma glucose concentration and glucose tubular reabsorption are presented in Table V . In four of six experiments glycosuria occurred in the absence of hyperglycemia and only on the side infused with salicylate.
Effect of salicylate on adenine nucleotides of the kidney. The concentrations of ATP, ADP, and AMP in cortex and medulla are presented in Table VI . Control data refer to concentrations reported elsewhere for a series of 10 normal dogs subjected to experimental conditions similar to those used in the present study (15) . In both studies the techniques of removal and freezing of the tissues were identical. In the cortex, the mean content of ATP in salicylate treated dogs was 0.37±0.06 SEM jmol/g wet weight, against 0.76±0.05 /mol/g wet weight in the controls. AMP content was 0.77+0.05 imol/g wet weight in the salicylate-treated dogs and 0.41±0.04 /mol/g wet weight in normal dogs. These differences were statistically significant by the double-tailed t test. There was no statistically significant difference in ADP content in the cortex between control and experimental dogs.
Control data for the medulla are from unpublished studies of one of the authors in six normal dogs (R. H. Kessler) . The mean concentration of ATP was essentially equal in both series, but-AMP and ADP were significantly higher in the salicylate-treated dogs than in the control dogs. and 0.52 mg/ml. The salicylate concentration in the injected renal artery was calculated to be about 1 mg/ml assuming a renal plasma flow of 3 times GFR. The concentration of salicylate was measured in cortex and outer and inner medulla of the left kidney. In every experiment there was a gradient in the concentration of salicylate from cortex to inner medulla that increased by a factor of 1.5 to 3. Chloride concentrations measured in these same tissue samples showed similar concentration gradients. These differences in concentration between cortex, outer medulla, and inner medulla were statistically significant. In experiments 27 and 28 of the systemic infusion variety (not presented in this table) the plasma salicylate concentration varied between 0.74 and 1.08 mg/ml, respectively, during the last experimental period. Salicylate clearances measured during these same periods varied between 8.4 and 11.2 ml/min.
DISCUSSION
We examined the acute effects of salicylate by injecting quantities sufficient to produce concentrations of salicylate of about 1 mg/ml of plasma. These levels are comparable to concentrations reported in the literature in cases of severe human intoxication (5, 9, 24 ,--------I nously and hyperventilation occurred, the administra-_-----tion of 5% CO in the inspired gas did not prevent enhancement of potassium excretion.
Salicylate also caused a prompt increase in potassium ---------and phosphate concentration in plasma followed later -------------.---by a phase of reduced concentrations of these ions. The (27) . From our data salicylate appears to block tubular s salicylate poisoning. Oliguria, frequently glucose reabsorption directly. Glycosuria occurred uniis more likely a late effect secondary to laterally when salicylate was administered into one water loss with concentration of the extra-renal artery. Furthermore, glucose appeared in the lume and reduction of filtration rate. urine at filtered loads far below the minimum reabm excretion was enhanced, occasionally ex-sorptive capacity of the dog kidney. e potassium filtered load. Increased potasHyperglycemia is known to occur in salicylate tox-!tion, frequently observed in salicylate poi-icity (6, 28) , and, in fact, was noted in all experiLs been attributed to respiratory alkalosis ments after intravenous infusion of salicylate. In some to hyperventilation (8, 9) . However, our cases the effect was biphasic; the early hyperglycemia [icate that the kaliuretic effect is a direct was followed by a late decline. The explanation for the it least partially independent of alkalosis.' initial hyperglycemia is not clear. However, it has 1 Because salicylate is incompletely reabsorbed, it could be expected to increase the electronegativity within the lumen of the distal tubule and, in this manner, enhance the excretion of potassium in a fashion similar to sulfate or ferrocyanate. Were this the sole explanation for the kaliuresis associated with the administration of salicylate, there should be at most a 1 to 1 stoichiometric relationship in the rates of excretion of potassium and salicylate.
In experiments 25 and 27 this relationship was examined; the rates of salicylate excretion equalled 73 and 61 .mole/ min, while potassium excretion in the same collection periods had increased to 164 and 160 ,mole/min from controls of 5 and 14 ;Lmole/min, respectively. We conclude, therefore, that the presence of unreabsorbed salicylate anion could account for only a fraction of the increment in the rate of potassium excretion. result in a reduction of energy for active transport.
Our observations are consistent with the hypothesis that oxidative phosphorylation provides a part of the energy for active ion transport in the kidney. The renal lesions of analgesic nephropathy are chiefly localized in the papilla and deep medulla. Such distribution of lesions could be explained if the offending drugs were concentrated in the kidney tissue. Bluemle and Goldberg reported that they could find no difference in salicylate concentration between cortex and medulla in the dog kidney (33) in contradiction with our results. Salicylate in our studies was concentrated in the medulla by a factor of 1.5-3 with respect to the cortex. This concentration gradient of salicylate was almost identical with that of chloride. Because during saline diuresis chloride is concentrated in the medulla secondary to the countercurrent system, the similarity of chloride and salicylate gradients suggests that salicylate may be concentrated by the same mechanism.
